CInMED — the Agency for Medicines and Medical Devices of Montenegro — registers every medical device placed on the Montenegrin market. Registration follows the framework set by the 2019 Law on Medical Devices, which is aligned with EU MDR (Regulation 2017/745). The practical workflow runs through a local distributor with a wholesale-of-medical-devices licence. This article walks through it step by step.
Who is CInMED?
CInMED is the national regulator for medicines and medical devices in Montenegro. The agency’s remit covers wholesale authorisation, device registration, import licensing, pharmacovigilance, and post-market surveillance. The official site is cinmed.me. The legal basis is the 2019 Law on Medical Devices — full text (PDF).
Who can file a CInMED registration?
A foreign manufacturer cannot file a CInMED registration directly. The filing party must be a Montenegrin entity with a CInMED wholesale-of-medical-devices licence — typically the authorised distributor. The distributor acts as the importer of record and as the local responsible-person for pharmacovigilance. Inter Pharm holds licence number 2050/22/482/2-6492 (cold chain authorised), and is named on CInMED’s public register at cinmed.me.
What goes into a registration dossier?
The dossier mirrors EU MDR expectations with a small set of national additions. The core documents are:
- EU Declaration of Conformity signed by the manufacturer, naming the device, class, and the applicable conformity-assessment route.
- CE certificate issued by the EU notified body (for Class IIa/IIb/III devices, IVDs Class B/C/D).
- Technical file in line with EU MDR Annex II/III: device description, design and manufacturing information, risk-management file, clinical evaluation report, post-market surveillance plan.
- Instructions for use (IFU) translated into Montenegrin (Latin script, ijekavica).
- Sample label as it will appear on the Montenegrin market.
- Manufacturer authorisation letter naming the Montenegrin distributor and the scope of the authorisation (territory, distribution status, duration).
- Free Sale Certificateor equivalent regulatory-status declaration from the manufacturer’s home authority.
- Administrative form + fee per the CInMED fee schedule.
What are the typical timelines?
Timelines vary by device class and dossier completeness. As a working benchmark for a complete dossier:
- Class I (low risk — e.g. surgical instruments, examination gloves): 3–5 weeks.
- Class IIa / IVD Class B (medium risk — e.g. infusion sets, ELISA assays): 4–7 weeks.
- Class IIb / IVD Class C (medium-high risk — e.g. blood-bag systems, PCR diagnostics): 6–9 weeks.
- Class III / IVD Class D (high risk — e.g. heart valves, implantable defibrillators, HIV/HCV assays): 8–12 weeks.
Incomplete dossiers add a clarification round of 2–4 weeks per missing item. The fastest route is to submit a complete, MDR-shaped dossier on day one — the local distributor handles document compilation, IFU translation, and label preparation before submission.
What does CInMED actually check?
CInMED’s review focuses on three axes. First, regulatory consistency — that the EU CE certificate and Declaration of Conformity match the device class declared in the technical file. Second, labelling and IFU compliance — that the Montenegrin-language label and IFU are accurate translations and meet the national language law. Third, the wholesale chain — that the named Montenegrin distributor holds a current CInMED wholesale licence covering the relevant device class and storage regime (cold chain, controlled access).
Clinical-evaluation evidence is reviewed at the same depth as under EU MDR. CInMED does not run a parallel clinical evaluation — the EU notified body’s assessment is the reference document.
What happens after registration?
Registered devices appear on the CInMED public register and may be placed on the Montenegrin market. Public-tender pre-qualification at KCCG and the regional general hospitals requires the registration to be active. Re-registration applies on a periodic cycle and on any material change to the device technical file. The local distributor handles renewals and vigilance reporting.
For broader market context — buyers, channels, EU MDR alignment — see the companion article The Montenegrin medical-device market in 2026.
Frequently asked questions
- How long does CInMED medical-device registration take?
- Typical end-to-end registration is 4–8 weeks once a complete dossier is filed with CInMED. Class I devices move fastest. Class IIa/IIb and Class III devices need additional clinical-evaluation evidence which can extend the review.
- Who can register a medical device in Montenegro?
- A registered local importer or wholesaler with a CInMED wholesale-of-medical-devices licence files the registration on behalf of the manufacturer. Foreign manufacturers cannot file directly — they appoint a Montenegrin authorised representative.
- What documents go into a CInMED registration dossier?
- EU Declaration of Conformity, CE certificate (if applicable), technical file in line with EU MDR Annex II/III, instructions for use translated into Montenegrin (Latin script), a sample label, the EU MDR risk class, and the manufacturer authorisation letter naming the local distributor.
- Does CInMED accept CE marking as sufficient?
- Montenegro's 2019 Law on Medical Devices is aligned with EU MDR (Regulation 2017/745). A valid CE certificate plus a complete EU MDR-conformant technical file is the baseline CInMED reviews against. National-level work focuses on labelling, IFU translation, and importer-of-record registration.
- What labelling requirements apply to medical devices in Montenegro?
- Labels and instructions for use must be in Montenegrin (Latin script, ijekavica). The manufacturer name, device class, batch/serial number, and the EU MDR UDI (where applicable) all appear unchanged from the CE-marked label. Translations are typically managed by the local distributor.
- Are there fees for CInMED registration?
- Yes. CInMED charges an administrative fee per registration. The fee schedule is published on cinmed.me and is updated periodically. Inter Pharm handles the fee payment as part of the standard distribution agreement.
